## Abstract The pathological basis for the dementia which occurs in 20 to 40% of patients with idiopathic Parkinson's disease (PD) remains uncertain. In the present postmortem study, we compared the prevalence and severity of parenchymal and vascular amyloid‐β (Aβ) deposition in the cerebral cortex
Amyloid β-protein deposition in the leptomeninges and cerebral cortex
✍ Scribed by Yasuhisa Shinkai; Maho Morishima-Kawashima; Dr. Yasuo Ihara; Masahiro Yoshimura; Hiroyuki Shimada; Yuji Ito; Katsuhiko Yanagisawa
- Publisher
- John Wiley and Sons
- Year
- 1997
- Tongue
- English
- Weight
- 950 KB
- Volume
- 42
- Category
- Article
- ISSN
- 0364-5134
No coin nor oath required. For personal study only.
✦ Synopsis
Postmortem delay ranged from 4 to 12 hours. These subjects, age 80 to 90 years (mean, 85.4 years), were examined thoroughly by general pathologists and neuropathologists, and none of them were diagnosed as having had AD. Five AD cases (68-84 years; mean, 76.8 years) were neuropatho-From the
📜 SIMILAR VOLUMES
Diffuse amyloid beta-protein (Abeta) deposits with numerous glial cells containing C-terminal Abeta fragments occur in the cerebral cortex of patients with Alzheimer's disease. By using a panel of antibodies specific for various epitopes in the Abeta peptide, we have investigated the immunohistochem
## Abstract The chronological relationship regarding deposition of amyloid β protein (Aβ) species, Aβ40 and Aβ42(43), was investigated in 16 brains from Down syndrome patients aged 31 to 64 years. The frontal cortex was probed with two end‐specific monoclonals that recognize Aβ40 or Aβ42(43). All s
Amyloid f3 protein (AD) deposition was investigated in the frontal cortex of 8 cases of (genetically confirmed) chromosome 14-linked Alzheimer's disease (AD) using the end-specific monoclonal antibodies BA27 and BC05 to detect the presence of AP4,, and AfL,2(431, respectively. In all patients, AP42(